Cargando…
The potential of herbal extracts to inhibit SARS-CoV-2: a pilot study
BACKGROUND: Herbal medicinal products have a long-standing history of use in the therapy of common respiratory infections. We sought to assess the potential of five validated herbal extracts regarding their ability to restrict SARS-CoV-2 replication in vitro: Bronchipret thyme-ivy (BRO TI), Bronchip...
Autores principales: | De Pellegrin, Michela Luisa, Rohrhofer, Anette, Schuster, Philipp, Schmidt, Barbara, Peterburs, Philipp, Gessner, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937545/ http://dx.doi.org/10.1186/s40816-021-00264-6 |
Ejemplares similares
-
Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab
por: Magnus, Clara Luzia, et al.
Publicado: (2022) -
In vitro Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2
por: Tran, Hoai Thi Thu, et al.
Publicado: (2022) -
New-onset Myasthenia Gravis after SARS-CoV-2 infection: case report and literature review
por: Tereshko, Yan, et al.
Publicado: (2022) -
Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
por: Mara, Elisabeth, et al.
Publicado: (2021) -
A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2
por: Gottsauner, Maximilian J., et al.
Publicado: (2020)